GLP2(T) 15mg

Chemical Information:

• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: 4813.53 g/mol
• Sequence: H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-γ-Glu-[2×AEEA]-Lys-Lys-Lys-Thr-Lys-Thr-Cys-OH (Modified and conjugated for enhanced receptor activity and prolonged half-life.)
• Molecular Structure: Refer to Certificate of Analysis for detailed structural information.

Description:
GLP2(T) is a synthetic peptide analog extensively studied in research due to its dual agonist activity targeting both GLP-1 and GIP receptors. Laboratory studies frequently utilize GLP2(T) to investigate peptide-mediated signaling mechanisms involved in glucose metabolism, lipid processing, nutrient sensing, and energy homeostasis. Provided as a lyophilized powder, GLP2(T) ensures stability and purity for controlled in vitro experimentation in metabolic research.

Research Applications:
GLP2(T) is actively researched in experimental models for potential roles in:

• Dual Receptor Activity Studies: Investigating signaling pathways related to glucose regulation and insulin sensitivity.
• Energy Intake and Satiety Pathways: Examining mechanisms that influence nutrient regulation, satiety signaling, and energy balance.
• Lipid and Metabolic Biomarker Analysis: Exploring interactions with lipid-related biomarkers and metabolic pathways.
• Multi-Receptor Peptide Research: Supporting studies into complex receptor interactions within metabolic regulation frameworks.

Storage and Handling:

• Store lyophilized powder at -20°C.
• After reconstitution, refrigerate at 2-8°C and use promptly.
• Maintain aseptic handling practices to ensure sterility and product integrity.

Product Specifications:

• Purity: ≥99% (HPLC Verified)
• Appearance: Lyophilized white powder
• Solubility: Soluble in bacteriostatic water

Important Note:
This product is strictly FOR RESEARCH USE ONLY and is intended exclusively for in vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and has not been evaluated by the FDA. This peptide is not intended to diagnose, treat, cure, or prevent any disease. The bodily introduction into humans or animals is strictly prohibited by law. Any misuse, misbranding, or mislabeling is a violation of federal regulations and may result in legal action under applicable federal, state, or local laws.

References:
Referenced scientific publications include:

• Drucker, D. J., et al. (2021). “Mechanisms of Action for Dual GIP and GLP-1 Receptor Agonists.” Nature Reviews Endocrinology.
• Frias, J. P., et al. (2020). “GLP2(T) for Glycemic Control and Weight Loss in Patients with Type 2 Diabetes.” The New England Journal of Medicine.